{"id":"W1926992252","doi":"10.1200/jco.2012.30.15_suppl.4519","title":"Primary, secondary, and quality-of-life endpoint results from the phase III AFFIRM study of MDV3100, an androgen receptor signaling inhibitor.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Université de Montréal","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Internal medicine; Interim analysis; Docetaxel; Adverse effect; Randomized controlled trial; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009903721,0.0001400659,0.00164284,0.00008070381,0.00006283229,0.000007508588,0.00017766,0.000233738,0.0001456695],"category_scores_gemma":[0.002917539,0.00007662743,0.0002409092,0.0001188259,0.0003570537,0.0001883404,0.0001085277,0.000923461,0.00000203711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000956922,"about_ca_system_score_gemma":0.001493353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002179581,"about_ca_topic_score_gemma":0.00006277941,"domain_scores_codex":[0.994279,0.00147359,0.003229925,0.0001929897,0.0005682621,0.0002562361],"domain_scores_gemma":[0.991106,0.005359914,0.002242675,0.0002818551,0.0004258668,0.000583653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2414773,0.04476791,0.3661188,0.0001456522,0.003520406,0.000134587,0.01691502,0.000004503364,0.02536198,0.00004713425,0.006418107,0.2950885],"study_design_scores_gemma":[0.2904408,0.1155536,0.5124047,0.0003534296,0.001426102,0.00005156486,0.01799197,0.00001873475,0.01287113,0.0001773322,0.04839195,0.0003186679],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927232,0.003167747,0.00001123855,0.002288846,0.0007030644,0.0004758391,0.00008131104,0.000004724293,0.000544013],"genre_scores_gemma":[0.9959167,0.000829624,0.0007925029,0.000435301,0.001911116,0.000003774839,0.00002902187,0.00001422241,0.00006775038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2947699,"threshold_uncertainty_score":0.401203,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2806508688257405,"score_gpt":0.5250663325708724,"score_spread":0.2444154637451319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}